Avara Pharmaceutical Technologies, Inc.
ManufacturerNEW CHEMICAL ENTITY#100+Ranks are based on product registered in particular category, doesn't reflect the market position
Approved products
2
Best category rank
#100+
Updated
22 May 2026
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Related Articles
An introduction to AIPharm - Making Good Pharmaceutical Data Accessible to Everyone
Manfye Goh · 2 min read
Bridging the Gap: Assessing Hypertension Drug Availability and Alignment with Malaysian CPG Guidelines and MOH Formulary
Manfye Goh · 12 min read
The 2022 New Health Supplement Products Analysis
Manfye Goh · 6 min read
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| Betmiga prolonged-release tablets 50mg | MAL15015107ACRZ | NEW CHEMICAL ENTITY | Astellas Pharma Malaysia Sdn Bhd | Avara Pharmaceutical Technologies, Inc. | ZUELLIG PHARMA SDN. BHD. | PRODUCT APPROVED |
| Betmiga prolonged-release tablets 25mg | MAL15015106ACRZ | NEW CHEMICAL ENTITY | Astellas Pharma Malaysia Sdn Bhd | Avara Pharmaceutical Technologies, Inc. | ZUELLIG PHARMA SDN. BHD. | PRODUCT APPROVED |
Betmiga prolonged-release tablets 50mg
Product Reg. noMAL15015107ACRZ
TypeNEW CHEMICAL ENTITY
Product HolderAstellas Pharma Malaysia Sdn Bhd
ManufacturerAvara Pharmaceutical Technologies, Inc.
ImporterZUELLIG PHARMA SDN. BHD.
Registration StatusPRODUCT APPROVED
Betmiga prolonged-release tablets 25mg
Product Reg. noMAL15015106ACRZ
TypeNEW CHEMICAL ENTITY
Product HolderAstellas Pharma Malaysia Sdn Bhd
ManufacturerAvara Pharmaceutical Technologies, Inc.
ImporterZUELLIG PHARMA SDN. BHD.
Registration StatusPRODUCT APPROVED
Rows per page:
1–2 of 2